Comparisons of baseline characteristic and outcomes
| Baseline Characteristics and Outcomes | Historical Cohort (03/15/2018–03/14/2019; n=34) | PDA prophylaxis cohort (03/15/2019–03/14/2020; n=43) | p value | |
|---|---|---|---|---|
| Excluded/Screened Infants, n/N | 29/63 | 31/74 | 0.2 | |
| Birthweight (grams), mean±SD | 754 ± 124 | 728 ± 122 | 0.4 | |
| Gestational age (completed weeks), mean±SD | 25.2 ± 1.2 | 25.3 ± 1.2 | >0.9 | |
| Acute Kidney Injury, n (%) | 6 (18) | 9 (21) | 0.7 | |
| Stages of AKI, n (%) | Stage 1 | 5 (83) | 8 (89) | 0.8 |
| Stage 2 | 1 (17) | 1 (11) | >0.9 | |
| Stage 3 | 0 (0) | 0 (0) | NA | |
| Subsequent PDA treatment, n (%) | 19 (56) | 13 (30) | 0.02 | |